A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder

Cornelis F. Vos; Marieke J.H. Coenen; Sophie E. ter Hark; Rob E. Aarnoutse; Arnt F.A. Schellekens; Joost G.E. Janzing

doi:10.1016/j.euroneuro.2024.09.002

A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder

Cornelis F. Vos^*
, Marieke J.H. Coenen
, Sophie E. ter Hark
, Rob E. Aarnoutse
, Arnt F.A. Schellekens
, Joost G.E. Janzing

^*Corresponding author for this work

Clinical Chemistry

Radboud University Medical Center
Donders Institute for Brain, Cognition and Behaviour
Antes (AntesZorg)
Radboud University Nijmegen

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

18 Downloads (Pure)

Original language	English
Pages (from-to)	56-57
Number of pages	2
Journal	European Neuropsychopharmacology
Volume	89
DOIs	https://doi.org/10.1016/j.euroneuro.2024.09.002
Publication status	Published - Dec 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.euroneuro.2024.09.002

1-s2.0-S0924977X24007302-mainFinal published version, 294 KBLicence: Article 25fa Dutch Copyright Act

Cite this

@article{d0d5e0e118c74657a78799048410855c,

title = "A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder",

author = "Vos, \{Cornelis F.\} and Coenen, \{Marieke J.H.\} and \{ter Hark\}, \{Sophie E.\} and Aarnoutse, \{Rob E.\} and Schellekens, \{Arnt F.A.\} and Janzing, \{Joost G.E.\}",

year = "2024",

month = dec,

doi = "10.1016/j.euroneuro.2024.09.002",

language = "English",

volume = "89",

pages = "56--57",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

}

TY - JOUR

T1 - A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder

AU - Vos, Cornelis F.

AU - Coenen, Marieke J.H.

AU - ter Hark, Sophie E.

AU - Aarnoutse, Rob E.

AU - Schellekens, Arnt F.A.

AU - Janzing, Joost G.E.

PY - 2024/12

Y1 - 2024/12

UR - https://www.scopus.com/pages/publications/85204804783

U2 - 10.1016/j.euroneuro.2024.09.002

DO - 10.1016/j.euroneuro.2024.09.002

M3 - Article

C2 - 39341084

AN - SCOPUS:85204804783

SN - 0924-977X

VL - 89

SP - 56

EP - 57

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -

A higher desmethylclomipramine to clomipramine ratio predicts more effectiveness and fewer adverse effects in major depressive disorder

UN SDGs

Access to Document

Other files and links

Cite this